In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Close this windowThis post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Next Tuesday 22 March at 7pm
REGISTER NOW: Immunisation update 2022
Webinar audience: GPs, practice nurses, practice staff and pharmacists.
Please join us for our annual Immunisation update, with the latest clinical information regarding the 2022 Influenza season, COVID-19 update and more.
This event will focus on information and forecasts for the upcoming 2022 influenza season, including guidelines for the new vaccines. The session aims to ensure immunisation providers are aware of the importance of adhering to the NSW Immunisation Schedule and ensuring children are kept up to date with their vaccination requirements. Reporting requirements will also be covered in the presentation.
All general practices must now register for an AIR provider number for their organisation for the purposes of sending immunisation data to the Australian Immunisation Register (AIR) – see NSW Health website. You will need to link this number to your practice software (e.g. Best Practice, Medical Director) to send immunisation data to the AIR.
Next steps:
PKI site certificates must be renewed to continue to transact digitally for Medicare and PBS. NASH PKI certificates must be renewed online through HPOS.
Register for the NCIRS webinar: Japanese encephalitis virus – an update for Australian clinicians, Thursday, 17 March 2022, 7:00 pm – 8:15 pm (AEDT),
On 4 March, Australia’s Acting Chief Medical Officer has declared the unfolding situation in Australia concerning the Japanese encephalitis virus (JEV) a Communicable Disease Incident of National Significance.
On 11 March, Greg Hunt announced the government will invest $69 million to control the spread of the Japanese encephalitis virus (JEV), including $28.18 million to purchase additional JEV vaccines – to be available from late March and into April.
There are two human JEV vaccines available on the Australian private market:
See advice regarding vaccination against Japanese encephalitis virus from the Communicable Diseases Network Australia (CDNA) Japanese encephalitis Sub-Group. Read The Conversation article: Do I or my child need a Japanese encephalitis vaccine?
On 2 March, ATAGI recommended the use of the Novavax vaccine as a booster in Australians aged 18 and over where an mRNA vaccine is not suitable.
Read the latest recommendations.
AusVaxSafety has published active safety surveillance data for dose 1 of Novavax COVID-19 vaccine. These data provide a profile of what to expect in the days following Novavax COVID-19 vaccination.
The COVID-19 Vaccination Training Program has released a new additional module for Moderna (6 to 11 years). All immunisation providers must complete the additional age specific training modules.
Many of the existing modules have also been updated with new information to reflect the latest ATAGI recommendations.
This A3 poster, updated 10 March, provides key differences between each COVID-19 vaccine approved for use in Australia as per the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines.
This report, updated 15 March, lists the percentage of people aged between 5-11 years old who have been vaccinated against COVID-19 by local government area (LGA). CESPHN is concerned about low vaccination rates in children and general practices are encouraged to identify those families who require vaccination support.
The first NCIRS webinar for 2022 looked at where we are and where we are headed as we move into the third year of the COVID-19 pandemic. Watch to hear from our expert speakers on:
Video now available: How do we get to immunisation business as usual while living with SARS-CoV-2?
Presented by Karen Booth, President of Australian APNA, the CESPHN Nurse Orientation webinar aimed at helping practices nurses new to primary health care and general practice.
Details: Tuesday 24 May 2022 | 7.00pm to 8.30pm | Register now
An educational webinar tailored for nurses on herpes zoster (shingles) vaccination for Australian adults ≥50 years of age. The webinar aims to enhance nurses knowledge of shingles and its prevention with Shingrix, a non-live shingles vaccine available in Australia.
Details: Tuesday 22 March 2022 | 7:00pm – 8:30pm AEDT | Register here
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Details: Thursday 17 March 2022, 11:30am (AEDT) | Click link to join
Catch up on previous webinars.
Catch up on previous Immunisation Weekly Updates.
Key updates in the NSW Pharmacist Vaccination Standards:
%MCEPASTEBIN%
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
